Delivery Order SPE2DB22D1106-SPE2DB25FEZG2
- Not listed
- The Defense Logistics Agency awarded a $2,248.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a common antibiotic medication used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $2,890.58, represents a non-set-aside competitive award with an ultimate completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,107.14 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ceftriaxone 1 GM-D5W bags. This contract has an ultimate completion date of September 14, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- This federal contract award, valued at $1,773.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ceftriaxone 2 GM-D5W bags, a type of antibiotic medication, with an ultimate completion date of April 16, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,567,927,129 units of the antibiotic Ceftriaxone 1 GM-D5W Bags, with a ceiling value of $1,432.71. The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,477.10 fixed-price delivery order is for the supply of Ceftriaxone 2 GM-D5W bags, a critical antibiotic medication. The contract has an ultimate completion date of December 17, 2024 and was awarded on December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,025.88 firm fixed-price delivery order is for the supply of Ceftriaxone 1 GM-D5W bags, a critical antibiotic medication. The contract has an ultimate completion date of November 26, 2024 and was awarded on November 25, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency Troop Support Medical awarded a $197,910 delivery order to Amerisourcebergen Drug Corporation for ceftriaxone sodium 2 grams/50 milliliters intravenous solution. The contract has a firm fixed price and requires delivery to a facility in Conshohocken, Pennsylvania by July 18, 2023. Amerisourcebergen will fulfill the order from its corporate headquarters. As a component of the Department of Defense, the Defense Logistics Agency supports America's armed forces by...
- The Defense Logistics Agency awarded a $4,749 delivery order contract to Amerisourcebergen Drug Corporation for the provision of 2 grams per 50 milliliters of ceftriaxone sodium and dextrose. The contract has a firm fixed price and requires delivery to a facility in Conshohocken, Pennsylvania by August 4, 2023. As a major supplier of pharmaceuticals to the Department of Defense, this award supports DLA's stockpile of essential medical supplies and will help ensure troops have needed...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,195.57, is for the delivery of Ceftriaxone 1 GM-D5W bags, a critical medical commodity. The contract has a firm-fixed price pricing type and an ultimate completion date of February 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZG2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,477.74 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Ceftriaxone is a third-generation cephalosporin antibiotic commonly used in military and veteran healthcare settings for treatment of bacterial infections. This delivery order is issued as a child contract under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical prime vendor contract enables the company to supply a broad range of medications, vaccines, and medical supplies to support Defense Health Agency operations and other federal healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement requirements through its extensive portfolio of delivery orders with the Defense Logistics Agency, demonstrating its capability to meet competitive federal acquisition standards across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 7/23/25 |